---
category: news
title: "Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy"
excerpt: "Neurophth Therapeutics, Inc., a subsidiary of Wuhan Neurophth Biotechnology Ltd. gene therapy company (hereafter Neurophth), and AAVnerGene Inc., a specializing AAV technology company, today announced a strategic partnership to provide Neurophth with worldwide rights to mutually select adeno-associatedÂ virus (AAV) capsids for the next generation ophthalmic gene therapy."
publishedDateTime: 2021-01-19T08:19:00Z
originalUrl: "https://www.medindia.net/health-press-release/Neurophth-and-AAVnerGene-Enter-Strategic-AAV-Capsids-Partnership-for-Next-Generation-Ophthalmic-Gene-Therapy-506755-1.htm"
webUrl: "https://www.medindia.net/health-press-release/Neurophth-and-AAVnerGene-Enter-Strategic-AAV-Capsids-Partnership-for-Next-Generation-Ophthalmic-Gene-Therapy-506755-1.htm"
type: article

provider:
  name: Medindia
  domain: medindia.net

topics:
  - AI in Healthcare
  - AI

secured: "yv1nD3PjcluQ+XheqXhf7mdcqnI6TcL80B8y8FvRqCKa7OODp0OGcRwPsQyDQ2agMdsth/FNYGS4qXgt11dgc0RKXIkIza0hygzeTaOMctFq2E2JLCqtsHFxNdQ+XsXGgKs4VBhC54l6bgXXJ2hnISy9RJhqhZ2nQavVFPxhW2CEKvkD6UZaAab+tQk3PPAbN2XVQv3EltPnizALbQd3GubFbb3rYdI5Rr7OgSYSPteVUkQ3r33eA2FRrv1UMdvBAxt327tEAy3Ir4MWYCK2LoQDtxrxcwQW8rPvaRxxSf3iZBZrj81vwgxrVw0gXQIESCbp7S/A/nu8/VA7DkhIK/LmCE5xGhu52aVRpDOhFZQ=;pvElIFeeTUY1941rT1HzlQ=="
---

